BUSINESS MODEL
NAUGEN aims to be a global innovation hub to incubate
multiple innovative portfolio companies or Special Purpose Companies (SPCs).
Special Purpose Companies
SPCs are NAUGEN’s portfolio companies created to develop and commercialize specific assets and/or technologies.
Each SPC operates as an independent entity, and NAUGEN provides each SPC with strategy, business development, and investor relations services in exchange for equity and/or service-based revenue.
NAUGEN works closely with strategic partners and investors to facilitate investment into the SPCs.
NAUGEN and Associate Companies
NAUGEN collaborates closely with selected strategic collaborators and an advisory group with top-tier global expertise across key functional areas.
Our strategic collaborators bring expertise in strategy & planning, business development, investor relations, intellectual property, legal affairs, science, research & development, clinical development and regulatory affairs.
KEY OBJECTIVE
NAUGEN dreams and works together with pioneering founders and inventors by creating a comprehensive strategy to accelerate establishment, funding, growth and monetization of innovative special purpose companies (SPCs) under its umbrella in a global perspective.
NAUGEN aims to grow its SPCs as globally reputable and influential companies that make a significant difference for people in need across the world.
VALUE PROPOSITION
We drive accelerated growth.
Identify innovative high-potential projects at a very early stage or before clinical PoC, while their potential value has not been recognized by the market.
In-license or merge & acquire synergistic components from multiple entities across the world and have them converge into an optimal vessel (SPC).
Implement a pivotal strategy & development plan to accelerate an exponential growth of the value.
OPTIONS FOR GROWTH AND EXIT
We help SPCs implement business development strategies for successful funding, growth and monetization at the right time.
GLOBAL NETWORK
Headquartered in the Washington, DC metro area, we connect with inventors and collaborators worldwide through our global network in strategic regions such as Korea and Japan, where innovations dynamically arise.
-
Biopharma ecosystem - NIH, FDA, etc.
-
Proximity to New York and Boston
-
Favorable living conditions
-
Favorable human resources environment
-
In-depth and creative science
-
The world-class bio/pharmaceutical ecosystem
-
Asian connection to China and Japan
-
Home of dynamic biotech innovation
-
Excellent clinical trial environment